Hans H Herfarth MD

Gastroenterology•Chapel Hill, NC

Professor, Medicine, University of North Carolina-Chapel Hill School of Medicine

Join to View Full Profile

130 Mason Farm Rd4151 BioinformaticsChapel Hill, NC 27599
Phone+1 984-974-0140
Fax+1 984-974-0395

Summary

Dr. Hans Herfarth is a gastroenterologist in Chapel Hill, NC and is affiliated with University of North Carolina Hospitals. He received his medical degree from Freie University Berlin Faculty of Medicine and has been in practice 26 years. He is experienced in general gastroenterology and inflammatory bowel disease.

Education & Training

Freie University Berlin Faculty of MedicineClass of 1992

Certifications & Licensure

NC State Medical License 2006 - 2026

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Fellow (AGAF) American Gastroenterological Association, 2010

Clinical Trials

Ciprofloxacin for the Prevention of Postoperative Endoscopic Recurrence in Crohn's Disease Start of enrollment: 2008 May 01
Completed
Phase 2
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis Start of enrollment: 2012 Feb 01
Completed
Phase 2
Trial of High Dose Vitamin D in Patient's With Crohn's Disease Start of enrollment: 2015 Apr 01
Terminated
Phase 4
Safety and Efficacy of Fecal Microbiome Transplantation (FMT) in the Treatment of Antibiotic Dependent Pouchitis (ADP) Start of enrollment: 2017 Jun 01
Terminated
Phase 1, Phase 2
Tofacitinib Response in Ulcerative Colitis - a Real World Prospective Multi-center Study Start of enrollment: 2018 Nov 27
Terminated
Efficacy of Liraglutide Therapy in Patients With IPAA Start of enrollment: 2022 Mar 22
TERMINATED
PHASE2
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Primary Prevention of Pouchitis.
Edward L Barnes, Hans Herfarth
Clinical Gastroenterology and Hepatology. 2025-08-01
Low Anti-Tumor Necrosis Factor Levels During Maintenance Phase Are Associated With Treatment Failure in Children With Crohn's Disease.
Jonathan Moses, Jeremy Adler, Shehzad A Saeed, Ann M Firestine, Joseph A Galanko
Inflammatory Bowel Diseases. 2025-07-07
MUSings on a Crohn's Disease Diagnosis.
Meera Iyengar, Animesh Jain, Hans H Herfarth, Millie D Long, Edward L Barnes
Digestive Diseases and Sciences. 2025-06-26

Journal Articles

Is There a Role for Thiopurines in IBD?
Raymond K Cross, Hans Herfarth, Nature
IBD LIVE Case Series: Case 9: Do Race and Extraintestinal Manifestations Affect Treatment of Severe Crohn’s Colitis?
David J Keljo, Joel R Rosh, Samir A Shah, Myron H Brand, Alka Goyal, Brian K Theisen, Hans H Herfarth, Walter A Koltun, Kim L Isaacs, Julia B Greer, Corey A Siegel, Ra..., Inflammatory Bowel Diseases

Press Mentions

Novel IL-7 Receptor Antagonist Shows Promise in Ulcerative ColitisMay 9th, 2025
ExeGi Pharma Positive Topline Results in EXE-346 PROF Phase 1b StudyDecember 17th, 2024
Proactive Therapeutic Drug Monitoring for BiologicsJune 1st, 2022
Join now to see all

Grant Support

Methotrexate Response In Treatment Of UC - Merit-UcNational Institute Of Diabetes And Digestive And Kidney Diseases2011
Methotrexate Response In Treatment Of UCNational Institute Of Diabetes And Digestive And Kidney Diseases2009
Clinical Trial: Ciprofloxacin For Prophylactic Prevention Of Postoperative EndosNational Center For Research Resources2008
Pilot Study On The Safety And Efficacy Of Ciprofloxacin For Prophylactic PreventiNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2008

Professional Memberships

American Gastroenterological Association - AGA
Fellow